Jinling Yi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance”.

FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.28.542643

N/A

0DataRank · unranked

1 citations

Wen‐Ming Cao, Feng Cheng, Zhongcheng Shi, Lili Han, Jinling Yi +8 more

FOXK2 amplification promotes breast cancer development and chemoresistance

Cancer Letters(2024)10.1016/j.canlet.2024.217074

N/A

0DataRank · unranked

11 citations

Wen‐Ming Cao, Feng Cheng, Zhongcheng Shi, Lili Han, Jinling Yi +8 more

Clarifying the role of the Mantel–Haenszel risk difference estimator in randomized clinical trials

Biometrics(2025)10.1093/biomtc/ujaf142

N/A

0DataRank · unranked

1 citations

Yi Qian, Jinling Yi, Jinqiu Wang, Yu Du, Yanyao Yi +2 more